|1.||Zimmermann, Martin: 6 articles (08/2015 - 11/2004)|
|2.||Reinhardt, Dirk: 6 articles (08/2015 - 11/2004)|
|3.||Creutzig, Ursula: 6 articles (08/2015 - 11/2004)|
|4.||Dworzak, Michael: 5 articles (08/2015 - 11/2004)|
|5.||Stary, Jan: 4 articles (06/2010 - 11/2004)|
|6.||Klusmann, Jan-Henning: 3 articles (08/2015 - 05/2010)|
|7.||Lehrnbecher, Thomas: 3 articles (05/2010 - 11/2004)|
|8.||von Neuhoff, Christine: 2 articles (08/2015 - 06/2010)|
|9.||Rasche, Mareike: 1 article (08/2015)|
|10.||Schweitzer, Jana: 1 article (08/2015)|
|1.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/01/2004 - "Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98."
07/01/1993 - "The current FAB classification of acute myelogenous leukemia (AML) by morphologic, immunologic and cytogenetic features is described and the incidence of subtypes and variant forms of AML in study AML-BFM-87 is given. "
11/01/2004 - "In a retrospective study, we analyzed incidence, clinical features, and risk factors for lethal complications of 901 children enrolled onto the multicenter trials Acute Myeloid Leukemia-Berlin-Frankfurt-Muenster (AML-BFM) 93 and AML-BFM 98. "
01/01/2012 - "In the multi-center AML-BFM 98 study we prospectively evaluated the impact of allogeneic stem cell transplantation in children with high-risk acute myeloid leukemia in first complete remission. "
01/01/2012 - "Our analyses defined a genetic subgroup of children with high-risk acute myeloid leukemia who benefited from allogeneic stem cell transplantation in the prospective multi-center AML-BFM 98 study. "
|2.||Chromosome Aberrations (Chromosome Abnormalities)
|3.||Down Syndrome (Down's Syndrome)
|1.||Granulocyte Colony-Stimulating Factor (G-CSF)
|2.||Surface Antigens (Surface Antigen)
|1.||Drug Therapy (Chemotherapy)
|2.||Stem Cell Transplantation
|3.||Bone Marrow Transplantation (Transplantation, Bone Marrow)